FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception.

HOME
>
論文・技術情報
>
FDA Adverse Event Reporting System Essentials: A Reflection on Study Conception.

アブストラクト
ジャーナル名	Clinical pharmacology and therapeutics
Pubmed追加日	2025/8/20
投稿者	Raschi, Emanuel; Cutroneo, Paola; Salvo, Francesco; Tuccori, Marco; Khouri, Charles
組織名	Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of;Bologna, Bologna, Italy.;Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre,;University Hospital of Messina, Messina, Italy.;Universite de Bordeaux, INSERM, BPH, Team AHeaD, U1219, Bordeaux, France.;CHU de Bordeaux, Service de Pharmacologie Medicale, INSERM, U1219, Bordeaux,;France.;Department of Diagnostics and Public Health, University of Verona, Verona, Italy.;Pharmacovigilance Unit, Grenoble Alpes University Hospital, Univ. Grenoble Alpes,;Grenoble, France.;Univ. Grenoble Alpes, Inserm U1300, HP2, Grenoble, France.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/40831079/